Cargando…
KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2
Hepatocellular carcinoma (HCC) is a common aggressive tumor with a poor prognosis, and patients often seem to be refractory to the use of therapeutic drugs. In this study, we found that the KLHL7 expression was upregulated in HCC that was associated with poor patient prognosis. KLHL7 has been found...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291331/ https://www.ncbi.nlm.nih.gov/pubmed/37378318 http://dx.doi.org/10.1016/j.isci.2023.106914 |